TARGET N V BIOTECH Insider Trading $CDTX Cidara Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for TARGET N V BIOTECH.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of TARGET N V BIOTECH. TARGET N V BIOTECH is 10% Owner in Monogram Biosciences, Inc. ($VLGC) and 10% Owner in Molecular Templates, Inc. ($MTEM) and 10% Owner in MACROGENICS INC ($MGNX) and 10% Owner in Radius Health, Inc. ($RDUS) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and 10% Owner in Cidara Therapeutics, Inc. ($CDTX).

TARGET N V BIOTECH in Cidara Therapeutics, Inc.

Trading Symbol: CDTX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of TARGET N V BIOTECH: 10% Owner
Holdings: 2,295,272 shares
Current Value: $22,034,611
Latest Transaction: Nov 16 2017
$CDTX Market Capitalization: $167.56M
$CDTX Previous Close: $9.60

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of TARGET N V BIOTECH in Cidara Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CDTX, ESPR, MGNX, MTEM, VLGC, RDUS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 16 2017CDTXCidara Therapeutic ...BIOTECH TARGET N V10% OwnerBuyP7.5760,000453,9662,295,2722.2 M to 2.3 M (+2.68 %)

Page:   1